Augmenting and Broadening T-cell Responses to Glioblastoma – Therapeutic Vaccine Platform Based on HCMV Expressing NKG2D Ligands

First 5 years of the CerVirVac: Symposium

Published on: 26. August 2022.

From September 2 – 3, 2022, a two-day symposium will be held at the University of Rijeka, Faculty of Medicine (hall 2), where the results of the first 5 years of the Scientific Center of Excellence for Viral Immunology and Vaccines will be presented.